Patents are a powerful tool for protecting technological innovations and recovering investment in research and development. However, acquiring and utilizing it requires a great deal of specialized knowledge, and a single misjudgment can bring years of development efforts to nothing. This article introduces typical failure patterns related to patents in the form of case studies, and explores lessons that can help prevent regrets like ``I wish I had done this then.''

Case 1: Conference presentation first, application later - classic pattern of loss of novelty

What happened

University researcher A has discovered an innovative catalytic reaction mechanism. This result was of great value both academically and industrially, and Mr. A could not contain his excitement and decided to present it at an international conference. The presentation was a great success, receiving praise from many researchers, and it was decided to submit it to an academic journal.

After the announcement, the industry-academia collaboration department at Mr. A's university began considering a patent application, but it was too late. The technical content had become publicly known through presentations at academic conferences, and as a general rule, it had lost its novelty. Although Japan has an ``exception for loss of novelty'' rule, Mr. A did not know the necessary procedures, and the time passed without being aware of the deadline of one year from the announcement. Even more seriously, when considering overseas applications, it became clear that many countries do not allow exceptions to the loss of novelty for applications filed after publication, making it hopeless to build a global patent portfolio.

What went wrong

Under patent law, "novelty" is an absolute condition for registration. If the content of an invention is made public before the application is filed, the invention becomes "publicly known" and, in principle, cannot be patented. "Publication" here includes conference presentations, paper presentations, exhibitions at exhibitions, posting on websites, and even oral explanations to third parties without confidentiality obligations.

In Japan, if the invention is published by the inventor himself/herself, he or she may be able to receive an exception to the loss of novelty by filing an application within one year of publication and following the prescribed procedures. However, this system is only an "exception" and is not recognized in all countries. The United States has a similar system (grace period), but under the European Patent Convention (EPC), disclosure by the inventor himself is, in principle, prior art that negates novelty. In other words, even if you apply after making a presentation at an academic conference, there is a high possibility that you will not be able to obtain a patent in Europe.

Lessons learned

When presenting research results and applying for patents, you should always follow the order of "application first, publication later." It is important to consult with the intellectual property department or a patent attorney from the early stages of presentation preparation, as there is a possibility that the content will already be considered public when an abstract is submitted for presentation at an academic conference.

For academic researchers, publishing papers and presenting at conferences is an important matter that is directly linked to performance evaluation, so there may be some resistance to waiting for patent applications. However, there is a grace period of 18 months from patent application to publication, and it is possible to submit papers and present at academic conferences during that time. Furthermore, even if the details of the invention are made public after the application has been filed, the novelty of the invention will not be affected. Research institutions are encouraged to educate their researchers on the basics of intellectual property strategies and to establish a system in which they always consult with intellectual property before making a presentation.

Case 2: A storm of “design avoidance” caused by too narrow a claim

What happened

Company B, a manufacturing equipment manufacturer, has developed a new conveyor device that dramatically improves production efficiency. The development team applied for a patent with full confidence and successfully received registration. The patent claims described the structure of the device in detail.

However, one year after the product was released, a competitor, Company C, released a transport device with almost the same functionality. Company B claimed patent infringement, but upon analysis of Company C's product, it was discovered that some of the components described in Company B's patent claims were different. Company B's patent included a structural limitation that ``the first roller and the second roller are arranged in parallel...'', but Company C was able to achieve the same function and avoid Company B's patent by ``arranging the rollers at an angle.''

Company B had no choice but to give up exercising its rights. Although it took three years to develop and the investment amounted to hundreds of millions of yen, the patent barrier to entry was virtually ineffective.

What went wrong

The scope of patent rights is defined by "claims." In principle, only products and methods that have all of the components listed in the claims fall within the scope of patent rights. Conversely, if even one component of a claim is missing, it does not constitute an infringement of rights, no matter how similar they may be technically.

Company B's problem was that its claims were overly specific and limited. Although the essence of the invention was an "efficient conveying mechanism," the claims were bound to a specific embodiment of "parallel arranged rollers." Competitors used this specific description as a clue to design around the product, using essentially the same idea to slip through the patent net.

Lessons learned

Claim drafting is one of the most important and difficult tasks in patent practice. A good claim is a hierarchical combination of broad claims that abstractly capture the essence of the invention (independent claims) and narrow claims that describe specific embodiments (dependent claims). Broad claims make it difficult to circumvent the design, while narrow claims provide a fallback for rejection during the prosecution process.

Inventors often try to explain in detail what they have actually created (an embodiment). However, when it comes to patent strategy, what is important is not ``what you made,'' but ``what you invented.'' The key to obtaining a valid patent is to extract the technical idea of ​​the invention and claim it in a way that is difficult for competitors to avoid. This work requires specialized experience and technology, and close cooperation with the patent office is essential.

Case 3: Conflict due to ambiguous "attribution of results" of joint development

What happened

Material manufacturer Company D and a university laboratory have signed a joint research and development agreement for a new material. Although there was a clause in the contract stating that ``the results of the joint research will be decided after consultation between both parties,'' it did not specify the ownership of specific rights or the burden of costs. The two parties had a good relationship and were optimistic that they could resolve the issue through discussion if the situation ever arises.

After two years of joint research, a groundbreaking invention was born. This is where the problem surfaced. Company D argued that the patent should belong to it because it had borne most of the research costs. On the other hand, the university argued that the core idea for the invention was created by a professor in the laboratory, and that the invention should at least be a joint application. Furthermore, when identifying inventors, opinions were divided as to whether engineers from the company should be included.

In the end, the patent application was significantly delayed, during which a third party's application related to similar technology took precedence. Relations between the two parties deteriorated, and the joint research was discontinued.

What went wrong

In joint research and development, leaving the ownership of intellectual property rights of a product ambiguous is like sowing seeds of conflict. In particular, regarding patent rights, there are a wide variety of matters that need to be agreed upon in advance, such as identifying the inventor, determining the applicant, cost burden, scope of license, and distribution of profits.

Under Japanese law, only a natural person (human being) can be an inventor, and the right to obtain a patent belongs to the inventor in principle. In the case of joint inventions, all joint inventors must file a joint application. In order for a company to acquire rights to an employee's inventions, rights must be inherited through employee invention regulations or a contract. In the case of joint research with a university, the university's employee invention regulations become intertwined, making the rights relationship even more complicated.

Lessons learned

When concluding a joint research and development agreement, agreements regarding the intellectual property rights of the results should be specified in concrete and detailed terms. The main issues to be discussed include the criteria for distinguishing between independent inventions and joint inventions, patent application procedures (who will take the initiative and how to bear the costs), ownership of rights (single ownership or joint ownership, what should be the percentage of ownership), establishment of license rights (conditions for licensing to the other party), whether licenses can be granted to third parties and revenue distribution, and the scope and duration of confidentiality obligations.

The clause "to be determined after consultation" may seem flexible at first glance, but it provides no guidance when there is a conflict of interest. When you have a good relationship, establishing clear rules for future conflicts is the foundation for maintaining a long-term cooperative relationship.

Case 4: Missing the national phase deadline for PCT applications—door to the world market is closed

What happened

Medical device venture Company E developed an innovative diagnostic device, filed a patent application in Japan, and then filed an international patent application (PCT application). By filing a PCT application, I thought I had secured the option of filing patent applications in multiple countries.

Company E was in a tight financial situation at the time, and the plan was to complete the transition procedures to each country (domestic phase transition) after financing was completed. However, raising funds took longer than expected, and by the time we realized that many countries had passed the national phase entry deadline (30 or 31 months from the priority date). The path to acquiring rights in the US and Europe, which were particularly important markets, was closed, and Company E was forced to fundamentally reconsider its global expansion strategy.

What went wrong

PCT (Patent Cooperation Treaty) filing is a convenient system that allows you to specify multiple countries with one international application, but it does not itself grant patent rights in each country. In order to actually obtain the rights, it is necessary to complete the procedure for entering the national phase with the patent office of each country (or region) within the specified deadline, submit a translation, and pay a fee.

In most countries, this deadline is 30 months from the priority date (usually the first filing date), but in some countries it is 31 months. If the deadline passes by even one day, it will generally be impossible to obtain rights in that country. Remedies are available in some countries, but their availability is uncertain and may involve additional costs.

In the case of Company E, there was a lack of understanding that ``just do the procedures later'' and deadline management was not thorough. Although there may have been an external factor such as delays in funding, the fundamental problem was a lack of sense of crisis as the deadline approached.

Lessons learned

When filing a PCT application, the deadline for entering the national phase must never be missed. A system should be in place to thoroughly manage deadlines and determine whether migration is necessary at least several months before the deadline.

Even if there are financial constraints, it may be possible to prioritize countries that are strategically important (major markets, manufacturing bases, countries where competitors are located, etc.) and decide to postpone other countries. It's important to prioritize based on business strategy rather than all-or-nothing.

Also, it is essential to build an organizational checking system rather than leaving deadline management to the person in charge. If you have an advisory agreement with a patent firm, we strongly recommend that you outsource deadline management and have a system in place to receive reminders.

Case 5: “Patent it” or “Keep it a secret”?—Error in strategic judgment

What happened

Chemical manufacturer F has developed a new catalyst formulation that greatly improves the efficiency of the manufacturing process. This formulation could not be reverse engineered from the product, and Company F decided that ``If we applied for a patent, the formulation would be made public, so it would be better to protect it as a trade secret.''

A few years later, Competitor G developed a nearly equivalent catalyst formulation through its own research and development and filed a patent application. Company F claimed that ``we developed it first,'' but they did not leave enough objective evidence (such as notarized documents to prove the date and time of development) to prove this. Once Company G's patent was registered, Company F was exposed to the risk of patent infringement even if it continued to use the conventional manufacturing method in its own factory.

What went wrong

There are two main ways to protect inventions: patents and trade secrets. A patent is a system that allows you to obtain exclusive rights for a certain period of time (20 years from the date of application) in exchange for making your invention public. On the other hand, trade secrets remain protected as long as they are kept secret and not disclosed, but they do not have exclusive rights.

What Company F overlooked was that even if it was protected as a trade secret, there was a risk that a third party could independently make the same invention and obtain a patent. Japan has a system called "prior user rights," which allows a person who has been working on an invention in good faith before someone else applied for a patent to continue working on that invention. However, in order to claim prior user rights, it is necessary to prove that the product was in use before the application was filed. Company F did not systematically preserve the evidence necessary to prove this (development records, manufacturing records, dated technical documents, etc.), making it difficult to claim prior user rights.

Lessons learned

When deciding whether to use a patent or a trade secret, it is necessary to comprehensively consider the nature of the technology, the market environment, and your company's resources.

Patents should be selected for technologies that can be reverse engineered from the product, for areas in which competitors are likely to be working on similar development, and for technologies that can be expected to generate licensing income. On the other hand, possible cases in which trade secrets should be selected include process technologies that cannot be analyzed from the product, technologies that will continue to have value for more than 20 years, and technologies that, if made public, would give ideas to competitors.

Even when protecting information as a trade secret, it is essential to secure evidence to claim prior user rights just in case. Specifically, there are methods such as entering the date in the development record, obtaining the fixed date at a notary public office, adding a time stamp to the electronic data, and having outside witnesses (lawyers, patent attorneys, etc.) confirm the date. In addition, in order to protect information as a trade secret, it is necessary to develop a management system (access restrictions, confidential display, employee education, etc.) that meets the requirements for "secret management" under the Unfair Competition Prevention Act.

Case 6: Dispute with inventor caused by deficiencies in employee invention regulations

What happened

At the rapidly growing tech venture Company H, an excellent engineer, Mr. I, developed a groundbreaking algorithm during his tenure there, and Company H incorporated this into its products and achieved great success. A patent was obtained and all seemed well.

However, Mr. I subsequently left Company H and moved to a competing company. After changing jobs, Mr. I requested a large sum of money from Company H, claiming that he had not been paid a reasonable amount of profit for his employee invention. Company H had employee invention regulations, but the content was only a formality, the standards for calculating consideration were vague, and there were not sufficient consultation procedures with employees.

The court found that Company H's employee invention regulations did not properly follow procedures such as consultation with employees and hearing their opinions, and ordered Company H to pay a considerable amount as "reasonable profits" rather than compensation based on the regulations.

What went wrong

Japan's Patent Law allows employers (companies) to obtain the right to obtain patents in advance for inventions made by employees in the course of their duties (employee inventions) (Article 35 of the Patent Law). Many companies have established employee invention regulations based on this provision, and the rights to employee inventions belong to the company.

However, with the revision of the Patent Act in 2015, in order for employee invention regulations to be effective, it is now necessary not only to simply establish regulations, but also to meet procedural requirements such as holding discussions with employees and hearing their opinions when formulating or changing them. In addition, if the content of the consideration or benefits specified in the regulations is found to be ``unreasonable,'' the court can calculate a ``reasonable profit'' and order the payment.

Company H's regulations did not meet these procedural requirements and the standards for calculating consideration were unclear, resulting in a dispute.

Lessons learned

It is not enough for the Employee Invention Regulations to simply "exist" formally. In order to be legally effective and to increase employee motivation, it is necessary to include elements such as consultation and hearing of opinions from employees during the formulation process, clarification of standards for calculating consideration and profits (contribution to sales, licensing income, cost reduction effects, etc.), specific provisions on payment timing and method, periodic review and dissemination to employees.

Particularly in R&D-based companies, appropriate incentive design for inventions is important for securing and retaining excellent human resources. It would be desirable to position employee invention regulations as a system for promoting innovation, rather than simply as a measure against legal risks, and to make them understandable to employees.

Case 7: Comments made during the screening process are a stumbling block—the trap of estoppel

What happened

Machine manufacturer J has filed a patent application for a new motor. During the examination process, I received a notice of reasons for refusal from the examiner pointing out similarities with prior art. In order to overcome this refusal, Company J's representative argued in a written opinion that ``a feature of the present invention is that the rotor magnets are arranged at a specific angle (30 degrees), and in this respect it is clearly different from the prior art,'' and the patent was successfully registered.

After that, Company J believed that competitor Company K's product infringed its patent, and filed a lawsuit. In Company K's product, the magnet placement angle was 25 degrees. Company J argued that ``25 degrees and 30 degrees are technically equivalent and substantially the same,'' but Company K argued that ``During the examination process, Company J obtained a patent by claiming that the ``30 degree arrangement'' was a feature of the invention.It violates estoppel to say that 25 degrees is now within the scope of the patent.''

The court accepted Company K's claim, and Company J lost the case.

What went wrong

This is an issue called "prosecution history estoppel" or "prosecution history estoppel." When interpreting the scope of patent rights, not only the wording of the claims but also the claims made by the applicant during the examination process are taken into account. If a patent is obtained by insisting on a specific and limited interpretation during the examination process, it may not be allowed under the principle of good faith to later claim that the meaning was actually broader.

In order to overcome the reasons for refusal, Company J emphasized the value of "30 degrees" as an essential feature of the invention, but this narrowed the scope of its rights. If the patent could have claimed the difference from the prior art in another way, it may have been able to maintain a broader scope of rights.

Lessons learned

Written opinions and amendments during the examination process are important documents that influence the exercise of rights after obtaining a patent. If you think only of overcoming the immediate reason for rejection and make a restrictive claim, it may hold you back later.

When preparing a written opinion, it is important to keep the limitations to the minimum necessary, not to present an overly narrow interpretation, to distinguish between essential and non-essential features of the invention, to consider differentiation in non-essential parts, and to carefully consider the impact of the claim with an eye to future rights enforcement.

This judgment requires a high level of expertise, so it is recommended to seek advice from an experienced patent attorney or patent attorney. Especially for important applications, it is necessary to have a strategic perspective at every stage of the examination process.

Summary: Tips for successful patent strategy

The lessons that can be drawn from these cases are wide-ranging, but can be summarized in a few core principles.

The first principle is "timing is important." The patent system has strict deadlines, such as filing timing to avoid the risk of loss of novelty, managing PCT national phase deadlines, and managing pension payment deadlines, and once an opportunity is missed, it is often impossible to recover. A ``I'll do it later'' attitude can lead to fatal consequences in the patent world.

The second principle is "strategic rights design." Claims that are too narrow may allow design avoidance, while claims that are too broad risk rejection at examination. The key to obtaining an effective patent is to accurately grasp the essence of the invention and design a scope of rights that is difficult for competitors to avoid and that can be registered.

The third principle is "documentation and securing evidence." Oral understandings and tacit assumptions, such as agreements on the ownership of rights in joint development, evidence of prior use when protecting a product as a trade secret, and the implementation of procedures under employee invention regulations, are of no use in the event of a dispute. Documenting all important matters and systematically preserving the necessary evidence will help prevent future disputes and prepare you in the event they arise.

The fourth principle is "cooperation with experts." Patent law is technically and legally complex, and when considering international development, differences in the legal systems of each country must be taken into account. No matter how many talented engineers there are in-house, it is difficult to internalize all patent work. The best way to prevent problems is to continually collaborate with experts such as patent attorneys and patent attorneys and receive consistent support from planning your application strategy to enforcing your rights.

Obtaining a patent is not an end in itself. It is a means to protect your business, build a competitive advantage, and recover your research and development investments. In order to make the most of these methods, it is essential to look at exit strategies from the technology development stage and consider intellectual property strategy and business strategy as one.

If you have any questions or would like to know more about a particular issue, please feel free to let us know. We can also consider scenarios tailored to individual situations and provide specific advice on preventive measures.

AUTHOR

Takefumi SUGIURA （杉浦 健文）

EVORIX Intellectual Property Law Firm　Managing Patent Attorney

Supports clients across IT, manufacturing, startups, fashion, and medical industries, covering patent, trademark, design, and copyright filings through trials and infringement litigation. Specialized in IP strategy for AI, IoT, Web3, and FinTech. Member of the Japan Patent Attorneys Association (JPAA), Asian Patent Attorneys Association (APAA), and Japan Trademark Association (JTA).

→ Patent Attorney Profile → Contact Us → Consultation Flow